<?xml version="1.0" encoding="UTF-8"?>
<!-- Dublin Core rendering of e1d59705-e50f-4e1a-b344-0c8a2ec8003b, generated by folio-assistant-core/scripts/dc-render.ts. Do not edit. -->
<!-- not expressible as DC XML (no DCMI element): who.relation.languageVersion -->
<metadata xmlns="https://litlfred.github.io/folio-assistant-core/v0/ns/dspace/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <dcterms:creator>World Health Organization</dcterms:creator>
  <dcterms:spatial xml:lang="en-US">Geneva</dcterms:spatial>
  <dc:date>2016-06-06T09:18:23Z</dc:date> <!-- dc.date.accessioned -->
  <dcterms:available xsi:type="dcterms:W3CDTF">2016-06-06T09:18:23Z</dcterms:available>
  <dcterms:issued xsi:type="dcterms:W3CDTF">2016-06-06</dcterms:issued>
  <dcterms:description xml:lang="en-US">429 p.</dcterms:description>
  <dcterms:abstract>This evidence-based guideline consolidates World Health Organization recommendations on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection, providing a comprehensive public health framework for HIV diagnosis, prevention, treatment, service delivery, and monitoring and evaluation across all age groups and populations. Developed in response to advances in scientific evidence and evolving programmatic needs, the second edition updates the 2013 consolidated guidelines and incorporates new recommendations, including universal eligibility for antiretroviral therapy (ART) regardless of CD4 cell count, expanded use of pre-exposure prophylaxis, and optimized approaches to HIV testing, treatment monitoring and management of coinfections and comorbidities. The guideline also outlines the methods used for guideline development and the principles underpinning a public health approach.

The publication provides evidence-based recommendations on HIV testing services, antiretroviral therapy, prevention interventions, differentiated service delivery models, linkage to care, adherence, decentralization, task sharing, laboratory services and programme monitoring. It emphasizes integrated, people-centred and community-based approaches to improve access to high-quality HIV services, strengthen health systems and support implementation in diverse epidemiological settings. Intended primarily for national HIV programme managers, clinicians, policy-makers and implementing partners, the guideline aims to accelerate progress towards universal access to HIV services and the global goal of ending the HIV epidemic as a major public health threat by 2030.</dcterms:abstract>
  <dc:identifier>9789241549684</dc:identifier> <!-- dc.identifier.isbn -->
  <dcterms:identifier xsi:type="dcterms:URI">https://iris.who.int/handle/10665/208825</dcterms:identifier>
  <dcterms:language>English</dcterms:language>
  <dcterms:language xsi:type="dcterms:RFC4646" xml:lang="en-US">en</dcterms:language>
  <dcterms:publisher xml:lang="en-US">World Health Organization</dcterms:publisher>
  <dcterms:relation>Related document (Policy brief, Programmatic document, Supplement):</dcterms:relation>
  <dcterms:relation>https://iris.who.int/handle/10665/198064</dcterms:relation>
  <dcterms:relation>https://iris.who.int/handle/10665/183599</dcterms:relation>
  <dcterms:relation>https://iris.who.int/handle/10665/255880</dcterms:relation>
  <dc:relation>https://iris.who.int/handle/10665/183599</dc:relation> <!-- dc.relation.haspart -->
  <dc:relation>https://iris.who.int/handle/10665/255880</dc:relation> <!-- dc.relation.haspart -->
  <dc:relation>https://iris.who.int/handle/10665/198064</dc:relation> <!-- dc.relation.hasversion -->
  <dcterms:subject xml:lang="en-US">WHO guideline</dcterms:subject>
  <dcterms:subject xsi:type="dcterms:MESH" xml:lang="en-US">HIV Infections</dcterms:subject>
  <dcterms:subject xsi:type="dcterms:MESH" xml:lang="en-US">Anti-Retroviral Agents</dcterms:subject>
  <dcterms:subject xsi:type="dcterms:MESH" xml:lang="en-US">Guideline</dcterms:subject>
  <dc:subject xml:lang="en-US">drug therapy</dc:subject> <!-- dc.subject.meshqualifier -->
  <dc:subject xml:lang="en-US">prevention and control</dc:subject> <!-- dc.subject.meshqualifier -->
  <dc:subject xml:lang="en-US">therapeutic use</dc:subject> <!-- dc.subject.meshqualifier -->
  <dcterms:title xml:lang="en-US">Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach</dcterms:title>
  <dc:title xml:lang="en-US">2nd ed</dc:title> <!-- dc.title.release -->
  <dcterms:type xml:lang="en-US">Publications</dcterms:type>
</metadata>
